Page 27 - Honorary Director News Today : Breaking News, Live Updates & Top Stories | Vimarsana

published : 25 Jan 2021 at 16:15 8 Siam Bioscience Co., Ltd., the first and only biopharmaceuticals manufacturer in Thailand, was founded in 2009 to preserve and continue what His Majesty the Late King Rama IX started on behalf of the Thai people’s health and wellbeing. The company’s main products are biopharmaceuticals. Its first product was erythropoietin (EPO) which is used to treat chronic renal failure patients who can no longer produce sufficient red blood cells, resulting in anaemia. Its second product was filgrastim (GCSF) for cancer patients receiving chemotherapy, who have high risk of infection due to low white blood cell counts. Manufactured using state-of-the-art biotechnology, both of these medicines are effective treatments with low side effects.

Nualphan lamsamCorporate communications of siam bioscience co ltdSiam cement groupMinistry of public healthDepartment of medical sciencesSiam bioscience co ltdNational vaccine instituteHis majestyLate king ramaSiam bioscienceMedical sciencesPublic healthSouth eastHonorary directorCorporate communicationsபெருநிறுவன தகவல்தொடர்புகள் ஆஃப் சியாம் உயிர் அறிவியல் இணை லிமிடெட்